Table of Content

1 Study Coverage
1.1 Biologics and Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Biologics and Biosimilars Market by Region
1.4.1 Global Biologics and Biosimilars Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Biologics and Biosimilars Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Biologics and Biosimilars Revenue by Players
2.1.1 Global Biologics and Biosimilars Revenue by Players (2019-2024)
2.1.2 Global Biologics and Biosimilars Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Biologics and Biosimilars Revenue in 2024
2.2 Global Biologics and Biosimilars Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Biologics and Biosimilars Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Roche
3.1.1 Roche Information
3.1.2 Roche Overview
3.1.3 Roche Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.1.4 Roche Related Developments
3.2 Amgen
3.2.1 Amgen Information
3.2.2 Amgen Overview
3.2.3 Amgen Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.2.4 Amgen Related Developments
3.3 AbbVie
3.3.1 AbbVie Information
3.3.2 AbbVie Overview
3.3.3 AbbVie Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.3.4 AbbVie Related Developments
3.4 Sanofi-Aventis
3.4.1 Sanofi-Aventis Information
3.4.2 Sanofi-Aventis Overview
3.4.3 Sanofi-Aventis Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.4.4 Sanofi-Aventis Related Developments
3.5 Johnson & Johnson
3.5.1 Johnson & Johnson Information
3.5.2 Johnson & Johnson Overview
3.5.3 Johnson & Johnson Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.5.4 Johnson & Johnson Related Developments
3.6 Pfizer
3.6.1 Pfizer Information
3.6.2 Pfizer Overview
3.6.3 Pfizer Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.6.4 Pfizer Related Developments
3.7 Novo Nordisk
3.7.1 Novo Nordisk Information
3.7.2 Novo Nordisk Overview
3.7.3 Novo Nordisk Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.7.4 Novo Nordisk Related Developments
3.8 Eli Lilly
3.8.1 Eli Lilly Information
3.8.2 Eli Lilly Overview
3.8.3 Eli Lilly Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.8.4 Eli Lilly Related Developments
3.9 Novartis
3.9.1 Novartis Information
3.9.2 Novartis Overview
3.9.3 Novartis Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.9.4 Novartis Related Developments
3.10 Merck
3.10.1 Merck Information
3.10.2 Merck Overview
3.10.3 Merck Biologics and Biosimilars Revenue and Gross Margin (2019-2024)
3.10.4 Merck Related Developments
4 Global Biologics and Biosimilars Market Insights
4.1 Global Biologics and Biosimilars Market Revenue 2019-2024
4.2 Global Biologics and Biosimilars Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Biologics and Biosimilars Revenue by Type
5.2 Global Biologics and Biosimilars Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Biologics and Biosimilars Revenue by Application
6.2 Global Biologics and Biosimilars Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Biologics and Biosimilars Market Size by Type
7.1.1 Americas Biologics and Biosimilars Revenue by Type (2019-2024)
7.1.2 Americas Biologics and Biosimilars Revenue Share by Type (2019-2024)
7.2 Americas Biologics and Biosimilars Market Size by Application
7.2.1 Americas Biologics and Biosimilars Revenue by Application (2019-2024)
7.2.2 Americas Biologics and Biosimilars Revenue Share by Application (2019-2024)
7.3 Americas Biologics and Biosimilars Market Size by Country
7.3.1 Americas Biologics and Biosimilars Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Biologics and Biosimilars Market Size by Type
8.1.1 Europe Biologics and Biosimilars Revenue by Type (2019-2024)
8.1.2 Europe Biologics and Biosimilars Revenue Share by Type (2019-2024)
8.2 Europe Biologics and Biosimilars Market Size by Application
8.2.1 Europe Biologics and Biosimilars Revenue by Application (2019-2024)
8.2.2 Europe Biologics and Biosimilars Revenue Share by Application (2019-2024)
8.3 Europe Biologics and Biosimilars Market Size by Country
8.3.1 Europe Biologics and Biosimilars Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Biologics and Biosimilars Market Size by Type
9.1.1 Asia Pacific Biologics and Biosimilars Revenue by Type (2019-2024)
9.1.2 Asia Pacific Biologics and Biosimilars Revenue Share by Type (2019-2024)
9.2 Asia Pacific Biologics and Biosimilars Market Size by Application
9.2.1 Asia Pacific Biologics and Biosimilars Revenue by Application (2019-2024)
9.2.2 Asia Pacific Biologics and Biosimilars Revenue Share by Application (2019-2024)
9.3 Asia Pacific Biologics and Biosimilars Market Size by Region
9.3.1 Asia Pacific Biologics and Biosimilars Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Biologics and Biosimilars Market Size by Type
10.1.1 Middle East and Africa Biologics and Biosimilars Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Biologics and Biosimilars Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Biologics and Biosimilars Market Size by Application
10.2.1 Middle East and Africa Biologics and Biosimilars Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Biologics and Biosimilars Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Biologics and Biosimilars Market Size by Country
10.3.1 Middle East and Africa Biologics and Biosimilars Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Biologics and Biosimilars Industry Trends
11.2 Biologics and Biosimilars Market Drivers
11.3 Biologics and Biosimilars Market Challenges
11.4 Biologics and Biosimilars Market Restraints
12 Biologics and Biosimilars Forecasted Market Size by Type
12.1 Global Biologics and Biosimilars Forecasted Revenue by Type
12.2 Global Biologics and Biosimilars Forecasted Market Size Growth by Type 2024-2030
13 Biologics and Biosimilars Forecasted Market Size by Application
13.1 Global Biologics and Biosimilars Forecasted Revenue by Application
13.2 Global Biologics and Biosimilars Forecasted Market Size Growth by Application 2024-2030
14 Global Biologics and Biosimilars Market Forecasts
14.1 Global Biologics and Biosimilars Market Revenue Forecasts 2024-2030
14.2 Global Biologics and Biosimilars Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Biologics and Biosimilars Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Biologics and Biosimilars Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Biologics and Biosimilars Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Biologics and Biosimilars Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer